NICE (UK) positive for Iqirvo (elafibranor) for previously treated primary biliary cholangitis when used with UDCA; or alone, if UDCA cannot be tolerated – Ipsen
NICE (UK): 1.1 Elafibranor is recommended, within its marketing authorisation, as an option for treating primary biliary cholangitis in adults, when used: i) with ursodeoxycholic acid (UDCA), if… read more.